Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

KOSDAQ:036480 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,875	3,630	4,362	3,852	4,395	5,212
Short-Term Investments	4,318	5,423	7,365	9,007	5,539	4,840
Cash & Short-Term Investments	9,193	9,053	11,727	12,859	9,935	10,052
Cash Growth	12.07%	-22.80%	-8.80%	29.44%	-1.17%	-19.61%
Accounts Receivable	3,133	3,779	4,131	3,040	2,986	3,675
Other Receivables	183.35	178.67	154.12	155.37	71.96	54.86
Receivables	3,316	3,958	4,285	3,196	3,058	3,730
Inventory	12,120	10,481	12,499	11,641	10,614	9,197
Prepaid Expenses	96.05	106.25	171.07	35.26	32.9	615.23
Other Current Assets	3.54	42.77	34.1	958.97	82.36	163.6
Total Current Assets	24,728	23,641	28,717	28,690	23,722	23,757
Property, Plant & Equipment	30,982	31,944	32,124	33,303	35,846	35,285
Long-Term Investments	1,161	1,310	1,498	1,256	1,327	1,346
Other Intangible Assets	355.85	354.8	356.77	354.83	356.3	358
Long-Term Deferred Tax Assets	282.92	574.44	734.47	134.47	355.46	374.75
Long-Term Deferred Charges	133.48	192.79	330.08	518.86	717.28	846.22
Other Long-Term Assets	500.91	361.62	530.37	852.47	295.71	295.71
Total Assets	58,144	58,379	64,290	65,109	62,620	62,263
Accounts Payable	1,976	1,318	1,543	977.94	768.84	1,237
Accrued Expenses	611.75	494.15	711.53	2,641	2,047	2,180
Short-Term Debt	1,500	1,000	5,319	2,000	700	877.56
Current Portion of Long-Term Debt	2,750	750	2,125	4,350	1,500	-
Current Portion of Leases	279.82	257.16	152.28	140.83	175.61	172.18
Current Income Taxes Payable	-	-	-	377.59	-	-
Other Current Liabilities	554.68	710.73	547.67	124.03	122.82	111.31
Total Current Liabilities	7,672	4,530	10,398	10,611	5,315	4,578
Long-Term Debt	15,500	18,125	16,375	15,500	19,850	20,550
Long-Term Leases	210.78	295.43	40.36	38.45	126.51	302.12
Other Long-Term Liabilities	295.03	279.04	127.98	122.51	130.67	-0
Total Liabilities	23,678	23,230	26,942	26,272	25,616	25,952
Common Stock	1,900	1,900	1,900	1,900	1,900	1,900
Additional Paid-In Capital	3,085	3,085	3,085	3,085	3,085	3,085
Retained Earnings	26,322	27,005	29,204	30,693	28,859	28,167
Comprehensive Income & Other	3,160	3,160	3,160	3,160	3,160	3,160
Shareholders' Equity	34,467	35,149	37,349	38,837	37,004	36,311
Total Liabilities & Equity	58,144	58,379	64,290	65,109	62,620	62,263
Total Debt	20,241	20,428	24,011	22,029	22,352	21,902
Net Cash (Debt)	-11,048	-11,374	-12,284	-9,170	-12,418	-11,850
Net Cash Per Share	-2907.34	-2993.19	-3232.58	-2413.27	-3267.79	-3118.43
Filing Date Shares Outstanding	3.8	3.8	3.8	3.8	3.8	3.8
Total Common Shares Outstanding	3.8	3.8	3.8	3.8	3.8	3.8
Working Capital	17,057	19,111	18,319	18,079	18,407	19,179
Book Value Per Share	9070.19	9249.83	9828.59	10220.37	9737.79	9555.62
Tangible Book Value	34,111	34,795	36,992	38,483	36,647	35,953
Tangible Book Value Per Share	8976.55	9156.47	9734.70	10127.00	9644.03	9461.40
Land	2,982	2,982	2,982	2,982	5,335	5,335
Buildings	15,741	16,026	16,596	17,167	17,741	17,791
Machinery	11,673	12,322	9,449	10,679	10,440	11,114
Construction In Progress	10	74.35	2,909	2,302	2,038	580.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.